about
Comprehensive geriatric assessment for older women with early breast cancer - a systematic review of literatureClinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancer.Biological characteristics and clinical outcome of triple negative primary breast cancer in older women - comparison with their younger counterparts.Tumour marker measurements in the diagnosis and monitoring of breast cancer.Preoperative endocrine therapy for breast cancer.Palpable asymmetrical thickening of the breast: a clinical, radiological and pathological study.Fulvestrant - a novel endocrine therapy for breast cancer.Long-term clinical outcome of oestrogen receptor-positive operable primary breast cancer in older women: a large series from a single centreInterruption and non-adherence to long-term adjuvant hormone therapy is associated with adverse survival outcome of breast cancer women--an Asian population-based study.Clinical relevance of "withdrawal therapy" as a form of hormonal manipulation for breast cancerConstruction of tissue microarrays from core needle biopsies - a systematic literature review.Successful management of elderly breast cancer patients treated without radiotherapy.Relationship between HbA1c and cancer in people with or without diabetes: a systematic review.Peri-Operative Management of Older Adults with Cancer-The Roles of the Surgeon and Geriatrician.Axillary reverse mapping in N0 patients requiring sentinel lymph node biopsy - A systematic review of the literature and necessity of a randomised study.The decision-making process for senior cancer patients: treatment allocation of older women with operable breast cancer in the UK.How relevant is breast cancer screening in the Asia/Pacific region?Bone metastases from breast carcinoma: histopathological - radiological correlations and prognostic features.Endocrine therapy for breast cancer: an overview.Biological effects of fulvestrant on estrogen receptor positive human breast cancer: short, medium and long-term effects based on sequential biopsies.The use of fulvestrant, a parenteral endocrine agent, in intestinal obstruction due to metastatic lobular breast carcinoma.Neoadjuvant chemotherapy for locally advanced breast cancer: a review of the literature and future directions.Ruptured gallbladder as the first presentation of breast cancerNeoadjuvant endocrine treatment in primary breast cancer - review of literature.Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer.Long-term (37 years) clinical outcome of older women with early operable primary breast cancer managed in a dedicated clinic.Management of operable primary breast cancer in older women.Primary breast cancer in the elderly: a systematic literature review on histological type and clinical outcome.Patient pathway for breast cancer: turning points and future aspirations.The role of primary endocrine therapy in older women with operable breast cancer.Controversial issues in the management of older adults with early breast cancer.A competing risk analysis of hormone therapy interruption in Asian women with breast cancer.Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial.Risks of nonadherence to hormone therapy in Asian women with breast cancer.Bridging the age gap in breast cancer: evaluation of decision support interventions for older women with operable breast cancer: protocol for a cluster randomised controlled trial.Suppression of ovarian function in combination with an aromatase inhibitor as treatment for advanced breast cancer in pre-menopausal women.The effects of gefitinib in tamoxifen-resistant and hormone-insensitive breast cancer: a phase II study.Locally advanced primary breast cancer: medium-term results of a randomised trial of multimodal therapy versus initial hormone therapy.A vision to optimise the management of primary breast cancer in older women.Bone turnover markers in postmenopausal breast cancer treated with fulvestrant--a pilot study.
P50
Q27002642-7D8AAF0E-87EF-4370-9A1B-7F881ACD1888Q33197385-D023A5CE-6813-4ADA-96AF-EBBCCA981C57Q33856732-74604FF7-BD5D-48D3-8FF7-6689449AE280Q33895357-31067BF9-E713-49EE-8658-C67B7C0BD74AQ34055111-E77F0C20-12E6-4937-9302-483C2C7D6E1BQ34271263-62CC3432-32A3-4C7F-865F-F08A6F2827A7Q34616724-232E894F-9F4C-4B48-9ABA-E32966CB753DQ35006855-E830F6B5-9E28-4F7A-92AF-BD6A2622FDA7Q35105896-0ADBB47C-70D6-4F11-998E-EDD0DF527B65Q35233126-46255FAA-A794-4AEE-A24C-D779CCDB9D3FQ35743491-92685B1E-E33B-4EE1-80CF-2C45FAE1E8B4Q35843731-58C32679-AFAD-4BC5-8514-576102C5E268Q35844397-743677D7-4C19-4D54-91A9-05CFA11B33D8Q36102861-E4BD421F-2E43-44BE-A34D-C875146C4145Q36304568-63315EC5-9060-498D-B4D2-2459F643AEBCQ36445752-66FA6877-21E2-4FDC-815E-A99B085AB10FQ36643058-AAC84CEB-7626-45E9-B86D-CFD9EB5F7BF4Q36648280-D9B05AEF-5536-45F3-90D7-05756689EF37Q36821144-EC30915D-5974-4703-9E9B-F1E885929472Q36933778-54DF5A10-C187-461F-95FE-A39D5B48C8B5Q37035869-1192E990-2DD1-4FD0-AB0F-6F7DD24429E7Q37172652-32BFD505-9C99-4E58-8F53-63FEBEFA2036Q37222073-EADA7AD5-0E11-47EF-9959-94005F854A48Q37616626-65FFDEB0-A205-4BA0-BA81-CF2A697D15F9Q37716464-6456B4D4-48D7-4EDD-AC19-645552CC6B8DQ37946357-9B079F38-A2A9-47ED-A2B7-47AC93BDB47FQ38254650-BA7626E6-BD27-42A2-B4FD-5F4B1C597A33Q38319569-46C6148D-4454-4B5B-925C-BAA3A66063B2Q38389148-A85FF1AA-A802-45DD-9CA7-B95BB724727CQ38473740-96B6E2BD-055A-4B30-B76A-35968880A7ABQ38731511-D72F5C89-D5AE-4BF9-804B-8BFC8654B7A3Q39076681-936C7E4D-0AA8-47F5-ABD3-381FF89990EFQ40446127-9DD6AA09-C73C-46D5-A680-2BDFE07DAE26Q40869332-D2F26A18-8FB6-40E3-ADD3-30C64E44590EQ42697893-A37C67C4-2DDF-456E-9AB2-082B7F621F97Q42910638-780BA486-22EB-47F3-B000-D251C7A2818BQ43279359-19B4E935-8A74-4F46-80F9-57841270B9E3Q43807545-FF660436-A25A-485B-A773-AC313F3166E8Q44715439-26811830-604A-4B55-8E21-26C2C8A9BA21Q45999590-F1A28E70-F253-4030-85B4-FD86FB4E0722
P50
description
researcher ORCID ID = 0000-0003-2973-0755
@en
wetenschapper
@nl
name
Kwok-Leung Cheung
@ast
Kwok-Leung Cheung
@en
Kwok-Leung Cheung
@es
Kwok-Leung Cheung
@nl
type
label
Kwok-Leung Cheung
@ast
Kwok-Leung Cheung
@en
Kwok-Leung Cheung
@es
Kwok-Leung Cheung
@nl
prefLabel
Kwok-Leung Cheung
@ast
Kwok-Leung Cheung
@en
Kwok-Leung Cheung
@es
Kwok-Leung Cheung
@nl
P106
P1153
55217380600
P31
P496
0000-0003-2973-0755